A Phase 1/2 Trial of Uproleselan Combined with High Dose Busulfan Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for Patients with Chemotherapy Resistant Acute Myeloid Leukemia

Grant

Total Award Amount

  • 71140.00
  • Direct Costs

  • 52309.00
  • Sponsor Award Id

  • Contributor

  • Joseph Chewning III M.D.   Principal Investigator